Wealth Enhancement Advisory Services LLC Takes Position in Plexus Corp. (NASDAQ:PLXS)

Wealth Enhancement Advisory Services LLC purchased a new position in shares of Plexus Corp. (NASDAQ:PLXS) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 1,518 shares of the technology company’s stock, valued at approximately $208,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Quest Partners LLC boosted its stake in Plexus by 36,700.0% during the 2nd quarter. Quest Partners LLC now owns 368 shares of the technology company’s stock worth $38,000 after purchasing an additional 367 shares during the period. Innealta Capital LLC acquired a new position in Plexus in the 2nd quarter valued at about $51,000. EntryPoint Capital LLC raised its stake in Plexus by 56.2% during the 1st quarter. EntryPoint Capital LLC now owns 976 shares of the technology company’s stock valued at $93,000 after acquiring an additional 351 shares during the last quarter. GAMMA Investing LLC grew its stake in shares of Plexus by 190.1% in the 3rd quarter. GAMMA Investing LLC now owns 760 shares of the technology company’s stock valued at $104,000 after purchasing an additional 498 shares during the last quarter. Finally, Signaturefd LLC increased its holdings in shares of Plexus by 12.0% in the second quarter. Signaturefd LLC now owns 1,705 shares of the technology company’s stock valued at $176,000 after purchasing an additional 183 shares during the period. 94.45% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Plexus

In other Plexus news, Director Karen Marie Rapp sold 500 shares of Plexus stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $128.02, for a total transaction of $64,010.00. Following the completion of the transaction, the director now owns 9,586 shares in the company, valued at approximately $1,227,199.72. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, Director Karen Marie Rapp sold 500 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $128.02, for a total transaction of $64,010.00. Following the completion of the transaction, the director now directly owns 9,586 shares of the company’s stock, valued at $1,227,199.72. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Oliver K. Mihm sold 5,691 shares of the stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $167.06, for a total value of $950,738.46. Following the sale, the chief operating officer now owns 19,585 shares in the company, valued at approximately $3,271,870.10. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 42,021 shares of company stock valued at $6,285,388. Insiders own 2.39% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. KeyCorp assumed coverage on shares of Plexus in a research report on Tuesday, October 22nd. They issued a “sector weight” rating on the stock. Benchmark lifted their target price on shares of Plexus from $150.00 to $165.00 and gave the company a “buy” rating in a report on Monday, October 28th. StockNews.com downgraded shares of Plexus from a “buy” rating to a “hold” rating in a research report on Wednesday, November 6th. Finally, Needham & Company LLC boosted their target price on Plexus from $144.00 to $162.00 and gave the stock a “buy” rating in a research report on Friday, October 25th. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, Plexus currently has an average rating of “Hold” and a consensus target price of $133.50.

Plexus Trading Down 1.6 %

Shares of Plexus stock opened at $160.58 on Wednesday. The company has a 50-day moving average of $137.48 and a two-hundred day moving average of $121.33. Plexus Corp. has a 12-month low of $90.18 and a 12-month high of $169.41. The company has a current ratio of 1.51, a quick ratio of 0.71 and a debt-to-equity ratio of 0.07. The stock has a market cap of $4.37 billion, a PE ratio of 40.04 and a beta of 0.87.

Plexus (NASDAQ:PLXS) last issued its quarterly earnings data on Wednesday, October 23rd. The technology company reported $1.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.55 by $0.30. The firm had revenue of $1.05 billion during the quarter, compared to analysts’ expectations of $1.01 billion. Plexus had a return on equity of 9.51% and a net margin of 2.82%. Plexus’s revenue was up 2.6% on a year-over-year basis. During the same period in the previous year, the firm posted $1.44 earnings per share. On average, research analysts anticipate that Plexus Corp. will post 6.2 EPS for the current fiscal year.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.